QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)

Compare Stocks

Enter up to ten stock symbols separated by a comma or space (ex. CSL,CTIB,VULC,ADSV,WST).

Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CSL
Carlisle Companies
$215.50
-1.9%
$237.10
$143.52
$250.23
$11.27B1.09248,733 shs369,791 shs
WST
West Pharmaceutical Services
$383.86
+1.4%
$423.95
$253.85
$475.35
$28.44B0.97550,815 shs714,489 shs
CTIB
Yunhong CTI
$0.90
-3.2%
$1.33
$0.85
$5.00
$5.30M0.58119,094 shs18,888 shs

MarketRank™

CompanyOverall ScoreAnalyst's OpinionCommunity RankDividend StrengthCompany OwnershipEarnings & Valuation
CSL
Carlisle Companies
2.80 of 5 Stars
2.44.73.31.71.9
WST
West Pharmaceutical Services
2.37 of 5 Stars
2.53.73.31.70.6
CTIB
Yunhong CTI
1.27 of 5 Stars
0.04.70.01.70.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CSL
Carlisle Companies
2.88
Buy$250.0016.01% Upside
WST
West Pharmaceutical Services
3.00
Buy$475.0023.74% Upside
CTIB
Yunhong CTI
0.00
N/AN/AN/A

Current Analyst Ratings

Latest CSL, CTIB, VULC, ADSV, and WST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
1/20/2022
CSL
Carlisle Companies
Robert W. Baird
Boost Price Target$250.00 ➝ $280.00
12/8/2021
CSL
Carlisle Companies
Oppenheimer
Boost Price TargetOutperform ➝ Outperform$255.00 ➝ $270.00
11/15/2021
CSL
Carlisle Companies
Zelman & Associates
Initiated CoverageBuy
(Data available from 1/27/2019 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CSL
Carlisle Companies
$4.25B2.65$9.95 per share21.65$47.54 per share4.53
WST
West Pharmaceutical Services
$2.15B13.25$6.41 per share59.93$25.03 per share15.34
CTIB
Yunhong CTI
$26.47M0.20N/AN/A($0.27) per share-3.33

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CSL
Carlisle Companies
$320.10M$7.0030.7916.331.178.16%17.46%7.05%2/10/2022 (Confirmed)
WST
West Pharmaceutical Services
$346.20M$8.0647.6342.601.5322.85%30.35%20.70%2/17/2022 (Estimated)
CTIB
Yunhong CTI
-$4.39MN/A0.00N/A-1.97%N/A-0.38%4/21/2022 (Estimated)

Latest CSL, CTIB, VULC, ADSV, and WST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/10/2022N/A
CSL
Carlisle Companies
$2.63N/A-$2.63N/AN/AN/A  
11/19/2021Q3 2021
CTIB
Yunhong CTI
N/A-$0.14-$0.14-$0.14N/A$6.23 million
10/28/20219/30/2021
WST
West Pharmaceutical Services
$1.80$2.06+$0.26$1.81$687.09 million$706.50 million    
(Earnings results data provided by Zacks Investment Research)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CSL
Carlisle Companies
$2.161.00%+38.31%30.86%46 Years
WST
West Pharmaceutical Services
$0.720.19%+21.05%8.93%29 Years
CTIB
Yunhong CTI
N/AN/AN/AN/AN/A

Latest CSL, CTIB, VULC, ADSV, and WST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/5/2022
WST
West Pharmaceutical Services
Quarterly$0.180.18%1/18/20221/19/20222/2/2022
11/1/2021
CSL
Carlisle Companies
Quarterly$0.540.95%11/16/202111/17/202112/1/2021
10/29/2021
WST
West Pharmaceutical Services
quarterly$0.180.2%11/9/202111/10/202111/17/2021
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CSL
Carlisle Companies
1.15
2.45
1.80
WST
West Pharmaceutical Services
0.10
2.86
2.23
CTIB
Yunhong CTI
N/A
1.18
0.50

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CSL
Carlisle Companies
93.82%
WST
West Pharmaceutical Services
90.12%
CTIB
Yunhong CTI
6.37%

Insider Ownership

CompanyInsider Ownership
CSL
Carlisle Companies
1.68%
WST
West Pharmaceutical Services
0.66%
CTIB
Yunhong CTI
49.7%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CSL
Carlisle Companies
12,00052.29 million51.41 millionOptionable
WST
West Pharmaceutical Services
9,20074.08 million73.59 millionOptionable
CTIB
Yunhong CTI
3665.89 million2.96 millionNot Optionable

CSL, CTIB, VULC, ADSV, and WST Headlines

SourceHeadline
Yunhong CTI (NASDAQ:CTIB) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00Yunhong CTI (NASDAQ:CTIB) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00
americanbankingnews.com - January 27 at 2:28 AM
Yunhong CTI Ltd. (NASDAQ:CTIB) Sees Large Drop in Short InterestYunhong CTI Ltd. (NASDAQ:CTIB) Sees Large Drop in Short Interest
americanbankingnews.com - January 19 at 12:32 PM
Yunhong CTI Ltd Shares Approach 52-Week Low - Market MoverYunhong CTI Ltd Shares Approach 52-Week Low - Market Mover
nasdaq.com - January 17 at 2:52 AM
Yunhong CTI Ltd. Common Stock (CTIB)Yunhong CTI Ltd. Common Stock (CTIB)
nasdaq.com - January 13 at 11:20 PM
Yunhong CTI (NASDAQ:CTIB) Share Price Passes Above 200-Day Moving Average of $0.00Yunhong CTI (NASDAQ:CTIB) Share Price Passes Above 200-Day Moving Average of $0.00
americanbankingnews.com - January 13 at 2:26 AM
Yunhong CTI Appoints Frank Cesario As CEOYunhong CTI Appoints Frank Cesario As CEO
finance.yahoo.com - January 11 at 7:47 PM
Yunhong CTI Ltd. Appoints Frank Cesario as Chief Executive Officer ...Yunhong CTI Ltd. Appoints Frank Cesario as Chief Executive Officer ...
pr-inside.com - January 11 at 9:46 AM
Yunhong CTI Ltd. Appoints Frank Cesario as Chief Executive Officer and Adds Three New Independent Board MembersYunhong CTI Ltd. Appoints Frank Cesario as Chief Executive Officer and Adds Three New Independent Board Members
finance.yahoo.com - January 11 at 9:46 AM
Is Yunhong CTI Ltd. (NASDAQ: CTIB) A Stock A New Investor Should Consider Now?Is Yunhong CTI Ltd. (NASDAQ: CTIB) A Stock A New Investor Should Consider Now?
stocksregister.com - November 27 at 11:05 AM
Yunhong CTI Ltd. (NASDAQ: CTIB): A Competitive Analysis And Growth ProspectsYunhong CTI Ltd. (NASDAQ: CTIB): A Competitive Analysis And Growth Prospects
marketingsentinel.com - November 24 at 8:19 AM
Is Yunhong CTI a Good Consumer Stock to Buy?Is Yunhong CTI a Good Consumer Stock to Buy?
stocknews.com - October 27 at 12:49 PM
Yunhong CTI Ltd. (NASDAQ: CTIB) 27.88% Incline Turns Investors AwayYunhong CTI Ltd. (NASDAQ: CTIB) 27.88% Incline Turns Investors Away
stocksregister.com - October 25 at 12:18 PM
Yunhong CTI Ltd. (CTIB)Yunhong CTI Ltd. (CTIB)
finance.yahoo.com - October 23 at 11:35 PM
Analysts Say Yunhong CTI Ltd. (NASDAQ:CTIB) Can Really Get To $7.00 In 12 MonthsAnalysts Say Yunhong CTI Ltd. (NASDAQ:CTIB) Can Really Get To $7.00 In 12 Months
marketingsentinel.com - October 22 at 3:44 PM
Yunhong CTI Ltd. (NASDAQ: CTIB) Recovered 32.52% From The 52-Week Low, And Now It’s 19.77% YTD – This Is What You Do NowYunhong CTI Ltd. (NASDAQ: CTIB) Recovered 32.52% From The 52-Week Low, And Now It’s 19.77% YTD – This Is What You Do Now
marketingsentinel.com - October 7 at 8:25 AM
Yunhong CTI Ltd. Announces New Credit AgreementYunhong CTI Ltd. Announces New Credit Agreement
finance.yahoo.com - October 7 at 3:25 AM
Thinking Of Selling Yunhong CTI Ltd. (NASDAQ: CTIB) Stock? Check This Out FirstThinking Of Selling Yunhong CTI Ltd. (NASDAQ: CTIB) Stock? Check This Out First
stocksregister.com - September 25 at 5:40 PM
Can Tupperware Brands Corporation (NYSE: TUP) Be A Safe Investment Now?Can Tupperware Brands Corporation (NYSE: TUP) Be A Safe Investment Now?
stocksregister.com - September 25 at 7:38 AM
Yunhong CTI Ltd. (NASDAQ: CTIB) Stock Forecast For 2021: $7.00 Per Share On The UpsideYunhong CTI Ltd. (NASDAQ: CTIB) Stock Forecast For 2021: $7.00 Per Share On The Upside
marketingsentinel.com - August 23 at 5:37 PM
Yunhong CTI Ltd. Announces Agreement to Sell its Flexo Universal BusinessYunhong CTI Ltd. Announces Agreement to Sell its Flexo Universal Business
finance.yahoo.com - August 10 at 12:45 PM
Yunhong CTI Ltd. (NASDAQ: CTIB) Is Becoming An Interest-Losing Stock With A -5.43% DeclineYunhong CTI Ltd. (NASDAQ: CTIB) Is Becoming An Interest-Losing Stock With A -5.43% Decline
marketingsentinel.com - August 2 at 7:56 AM
Yunhong CTI Ltd. (CTIB) Forecasts And Estimates For The Near FutureYunhong CTI Ltd. (CTIB) Forecasts And Estimates For The Near Future
marketingsentinel.com - July 26 at 9:48 AM
Yunhong CTI Ltd. (NASDAQ: CTIB) Gain Of 48.0% Compared To 52-Week Low; YTD Rise 45.35% – What Should You Do Now?Yunhong CTI Ltd. (NASDAQ: CTIB) Gain Of 48.0% Compared To 52-Week Low; YTD Rise 45.35% – What Should You Do Now?
marketingsentinel.com - July 18 at 8:05 AM
Yunhong CTI Ltd. (NASDAQ: CTIB): The Metrics That Matter Right NowYunhong CTI Ltd. (NASDAQ: CTIB): The Metrics That Matter Right Now
stocksregister.com - July 15 at 8:22 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.